 | Up a level |
Johnen, A.; Burkner, P. C.; Landmeyer, N. C.; Ambrosius, B.; Calabrese, P.; Motte, J.; Hessler, N.; Antony, G.; Konig, I. R.; Klotz, L.; Hoshi, M. M.; Aly, L.; Groppa, S.; Luessi, F.; Paul, F.; Tackenberg, B.; Bergh, F. T.; Kumpfel, T.; Tumani, H.; Stangel, M.; ... (2019). Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). Journal of neurology, 266(2), pp. 386-397. Springer-Medizin-Verlag 10.1007/s00415-018-9142-y
Classen, G.; Classen, C.; Bernasconi, Corrado Angelo; Brandt, C.; Gold, R.; Chan, Andrew; Hoepner, Robert (2019). Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Journal of neurovirology, 25(1), pp. 133-136. Springer 10.1007/s13365-018-0689-2
Thiel, S.; Leypoldt, F.; Röpke, L.; Wandinger, K.; Kümpfel, T.; Aktas, O.; von Bismarck, O.; Salmen, Anke; Ambrosius, B.; Ellrichmann, G.; Antony, G.; Dankowski, T.; Ziegler, A.; Stahmann, A.; Meyer, C.; Eichstädt, K.; Buckow, K.; Meißner, T.; Thibaut, J.; Khil, L.; ... (2018). Neuroimmunological Registries in Germany. Neurology international open, 02(01), E25-E39. Thieme 10.1055/s-0043-108830
Salmen, Anke; von Ahsen, N.; Trampe, A. K.; Hoepner, R.; Plavina, T.; Subramanyam, M.; Kuesters, G.; Gold, R.; Chan, Andrew (2016). Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy. Multiple sclerosis journal - experimental, translational and clinical, 2, p. 205521731663000. Sage Publications 10.1177/2055217316630008
